Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vomeronasal 2 receptor 1 pseudogene (VN2R1P, also known as GPRC2B) is annotated as a pseudogene in the human genome. It is a non-functional homolog of the vomeronasal 2 receptor family, which in rodents encodes G protein-coupled receptors (GPCRs) involved in pheromone detection within the vomeronasal organ. In humans, VN2R1P does not yield a functional receptor protein and is not involved in any known biological processes or disease roles. It is therefore not considered a therapeutic target or druggable protein. Its status as a pseudogene reflects either the loss of protein-coding potential or function throughout primate evolution, and it does not play a role in human physiology or pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 2 receptor 1 pseudogene (VN2R1P).